December 26, 2020
–
1
–
Brazil says China’s COVID vaccine is 50-90% effective, reveals Jan. 7 results
Health Minister of the State of Sao Paulo, Dr Sean Gorin Thayne, said: CoronaVac, a vaccine against COVID-19. That was developed by Sinovac. China’s biotech. Shows an effective antivirus protection of 50-90% in Brazil trials. And Sinovac vaccine maker in Brazil said All experimental results will be released on January 7, 2021.
São Paulo State’s Butantan Institute of Biological Research Center, which has an agreement with Sinovac to produce the COVID-19 vaccine, has disclosed. Sinovac vaccine trial results in Brazil
Dr. Gorin Thayne Giving interviews to CBN radio stations In a news broadcast on Thursday that Sinovac’s vaccine trials show 50-90% efficacy, 50% is the minimum set by Anvisa. Which is the Brazilian health regulator
Dr. Gorinchtayne said the state of Sao Paulo’s health ministry had not received all of Sinovac’s results. The company would like to review the data before the announcement of the final trial results.
The Butantan Institute It said on Friday that the institute will release data on the results of the Sinovag vaccine trial within 15 days or by January 7, 2021.
On Wednesday (23 Dec) ago Butantan Institute It declined to disclose specific information on the efficacy rates of Sinovac’s vaccine tested on 13,000 volunteers, saying the institution has a contractual commitment to Sinovac. Which refusing to disclose such experimental data It raised questions about the transparency of the results.
Worldometer, the latest data reporting website gathered from public health agencies around the world, said: Number of COVID-19 cases Brazil’s number is 7,448,560 and the death toll is 190,515.
– .
